⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9773765 | 1.00 | — | — | |
| SCHEMBL15971422 | 1.00 | — | — | |
| Chloromethane SCHEMBL28145551 | 0.93 | — | — | |
| SCHEMBL68569 | 0.86 | — | — | |
| SCHEMBL9773703 | 0.85 | EPHX2 (0.33) | — | |
| SCHEMBL13973741 | 0.85 | LMNA (0.31) | — | |
| SCHEMBL28539038 | 0.85 | — | — | |
| SCHEMBL14641415 | 0.83 | CA1 (0.38) | — | |
| SCHEMBL14463171 | 0.83 | CA1 (0.38) | — | |
| SCHEMBL22022206 | 0.83 | CA1 (0.38) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 5384 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12320012-B2 | Thermal atomic layer etching processes | ASM IP HOLDING B.V. (NL) | 2025-06-03 | — | — | US | claimed |
| CN-119708008-A | Preparation method of Marbalol Sha Wei intermediate | 山东科新药业有限公司 | 2025-03-28 | — | — | CN | claimed |
| CN-117886761-A | Pyrimidine derivative containing cyclopropane sulfonamido and pharmaceutically acceptable salt thereof, and preparation method and application thereof | 广东莱恩医药研究院有限公司 | 2024-04-16 | — | — | CN | claimed |
| US-20230374671-A1 | THERMAL ATOMIC LAYER ETCHING PROCESSES | ASM IP HOLDING B.V. (NL) | 2023-11-23 | — | — | US | claimed |
| CN-115160298-B | Tacrine-sulfonamide derivative and preparation method and application thereof | 中国人民解放军北部战区总医院 | 2023-05-23 | — | — | CN | claimed |
| EP-3601262-B1 | PROCESS FOR THE PREPARATION OF A SULFONAMIDE STRUCTURED KINASE INHIBITOR | AURIGENE DISCOVERY TECH LTD (IN) | 2022-11-09 | — | — | EP | claimed |
| CN-115160298-A | Tacrine-sulfonamide derivative and preparation method and application thereof | 中国人民解放军北部战区总医院 | 2022-10-11 | — | — | CN | claimed |
| CN-110446704-B | Process for the preparation of sulfonamide-structured kinase inhibitors | 奥赖恩公司 | 2022-07-05 | — | — | CN | claimed |
| CN-113651799-B | Six-membered non-aromatic ring-containing diaryl pyrimidine HIV-1 reverse transcriptase inhibitor and preparation method and application thereof | 山东大学 | 2022-06-17 | — | — | CN | claimed |
| CN-113651799-A | Six-membered non-aromatic ring-containing diaryl pyrimidine HIV-1 reverse transcriptase inhibitor and preparation method and application thereof | 山东大学 | 2021-11-16 | — | — | CN | claimed |
| EP-1833817-B1 | SYNTHESIS OF CCR5 RECEPTOR ANTAGONISTS | SCHERING CORP (US) | 2010-10-13 | — | — | EP | claimed |
| US-7728135-B2 | Synthesis of CCR5 receptor antagonists | SCHERING CORPORATION (US) | 2010-06-01 | — | — | US | claimed |
| US-20100063280-A1 | PROCESS FOR PREPARING CCR-5 RECEPTOR ANTAGONISTS UTILIZING 4-SUBSTITUTED 1-CYCLOPROPANE-SULFONYL-PIPERIDINYL COMPOUNDS | SCHERING CORPORATION | 2010-03-11 | — | — | US | claimed |
| US-20100036125-A1 | SYNTHESIS OF CCR5 RECEPTOR ANTAGONISTS | SCHERING CORPORATION | 2010-02-11 | — | — | US | claimed |
| EP-2125733-A1 | PROCESS FOR PREPARING CCR-5 RECEPTOR ANTAGONISTS UTILIZING 4-SUBSTITUTED 1-CYCLOPROPANE-SULFONYL-PIPERIDINYL COMPOUNDS | SCHERING CORPORATION (US) | 2009-12-02 | — | — | EP | claimed |
| WO-2008079284-A1 | PROCESS FOR PREPARING CCR-5 RECEPTOR ANTAGONISTS UTILIZING 4-SUBSTITUTED 1-CYCLOPROPANE-SULFONYL-PIPERIDINYL COMPOUNDS | SCHERING CORPORATION (US) | 2008-07-03 | — | — | WO | claimed |
| CN-101137646-A | Synthesis of CCR5 receptor antagonists | SCHERING CORP (US) | 2008-03-05 | — | — | CN | claimed |
| EP-1833817-A2 | SYNTHESIS OF CCR5 RECEPTOR ANTAGONISTS | SCHERING CORPORATION (US) | 2007-09-19 | — | — | EP | claimed |
| US-20060258863-A1 | Synthesis of CCR5 antagonists | SCHERING CORPORATION | 2006-11-16 | — | — | US | claimed |
| WO-2006074270-A2 | SYNTHESIS OF CCR5 RECEPTOR ANTAGONISTS | SCHERING CORPORATION (US) | 2006-07-13 | — | — | WO | claimed |